Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CDKN1A |
| Upstream (Parents) |
|---|
| (<<) CTGF → CDKN1A |
| (<<) CXCR7 → CDKN1A |
| (<<) ELK3 → CDKN1A |
| (<<) IL1B → CDKN1A |
| (<<) JUNB → CDKN1A |
| (<<) PLD2 → CDKN1A |
| Downstream (Children) |
|---|
| CDKN1A → ALOX15B (>>) |
| CDKN1A → BPGM (>>) |
| CDKN1A → CEBPE (>>) |
| CDKN1A → CXCL1 (>>) |
| CDKN1A → EHD1 (>>) |
| CDKN1A → EPHB6 (>>) |
| CDKN1A → GNA15 (>>) |
| CDKN1A → GNAL (>>) |
| CDKN1A → ID1 (>>) |
| CDKN1A → NFIB (>>) |
| CDKN1A → NFKBIE (>>) |
| CDKN1A → PTGS2 (>>) |
| CDKN1A → RND3 (>>) |
| CDKN1A → SIGLEC15 (>>) |
| CDKN1A → SMAD5 (>>) |
| CDKN1A → SPRR1A (>>) |
